The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow,Elias Campo,Stefano Pileri,Nancy L. Harris,Harald Stein,Reiner Siebert,Ranjana H. Advani,Michele Ghielmini,Gilles Salles,Andrew D. Zelenetz,Elaine S. Jaffe +10 more
TLDR
The revision clarifies the diagnosis and management of lesions at the very early stages of lymphomagenesis, refines the diagnostic criteria for some entities, details the expanding genetic/molecular landscape of numerous lymphoid neoplasms and their clinical correlates, and refers to investigations leading to more targeted therapeutic strategies.About:
This article is published in Blood.The article was published on 2016-05-19 and is currently open access. It has received 5321 citations till now.read more
Citations
More filters
Journal ArticleDOI
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study.
Jeremy S. Abramson,M. Lia Palomba,Leo I. Gordon,Matthew A. Lunning,Michael Wang,Jon E. Arnason,Amitkumar Mehta,Enkhtsetseg Purev,David G. Maloney,Charalambos Andreadis,Alison R. Sehgal,Scott R. Solomon,Nilanjan Ghosh,Tina Albertson,Jacob Garcia,Ana Kostic,Mary Mallaney,Ken Ogasawara,Kathryn Newhall,Yeonhee Kim,Daniel Li,Tanya Siddiqi +21 more
TL;DR: Overall safety and activity of liso-cel did not differ by dose level, with a high objective response rate, and a low incidence of grade 3 or worse cytokine release syndrome and neurological events in patients with relapsed or refractory large B-cell lymphomas.
Journal ArticleDOI
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
TL;DR: The cancer burden attributed to human papillomavirus showed the clearest relationship with country income level, and infection-attributable cancer incidence allows for refined geographic analyses and identification of populations with a high infection-associated cancer burden.
Journal ArticleDOI
2016 US lymphoid malignancy statistics by World Health Organization subtypes.
Lauren R. Teras,Carol DeSantis,James R. Cerhan,Lindsay M. Morton,Ahmedin Jemal,Christopher R. Flowers +5 more
TL;DR: Estimates of the total numbers of US lymphoid neoplasm cases by subtype as well as a detailed evaluation of incidence and survival statistics are presented, which can offer clues regarding their etiology.
Journal ArticleDOI
Infection in Organ Transplantation
TL;DR: Transplant infectious disease remains a key to the clinical and scientific investigation of organ transplantation and application of quantitative molecular microbial assays and advanced antimicrobial therapies have advanced care.
Journal ArticleDOI
International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data.
Daniel A. Arber,Attilio Orazi,Robert P. Hasserjian,Michael Horowitz,Katherine R. Calvo,Hans Michael Kvasnicka,Sa A. Wang,Adam Bagg,Tiziano Barbui,Susan Branford,Carlos E. Bueso-Ramos,Jorge E. Cortes,Paola Dal Cin,Courtney D. DiNardo,Hervé Dombret,Eric J. Duncavage,Benjamin L. Ebert,Elihu H. Estey,Fabio Facchetti,Kathryn Foucar,Naseema Gangat,Umberto Gianelli,Lucy A. Godley,Nicola Goekbuget,Jason Gotlib,Eva Hellström-Lindberg,Gabriela S. Hobbs,Roald Hoffmann,Elias Jabbour,Jean-Jacques Kiladjian,Richard A. Larson,Michelle M. Le Beau,Mignon L. Loh,Bob Löwenberg,Elizabeth Macintyre,Luca Malcovati,Charles G. Mullighan,Charlotte M. Niemeyer,Olatoyosi Odenike,Seishi Ogawa,Alberto Orfao,Elli Papaemmanuil,Francesco Passamonti,Kimmo Porkka,C H Pui,Jerald P. Radich,Andreas Reiter,María Rozman,Martina Rudelius,Michael R. Savona,Charles A. Schiffer,Annette Schmitt-Graeff,Akiko Shimamura,Jorge Sierra,Wendy Stock,Richard Stone,Martin S. Tallman,Juergen Thiele,Hwei-Fang Tien,Alexandar Tzankov,Alessandro M. Vannucchi,Paresh Vyas,Andrew H. Wei,Olga Weinberg,Agnieszka Wierzbowska,Mario Cazzola,Hartmut Döhner,Ayalew Tefferi +67 more
TL;DR: The authors, a group with expertise in the clinical, pathologic and genetic aspects of these disorders, developed the International Consensus Classification (ICC), aimed at facilitating diagnosis and prognostication of these neoplasms, improving treatment of affected patients, and allowing the design of innovative clinical trials.
References
More filters
Journal ArticleDOI
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.
Ramona Crescenzo,Ramona Crescenzo,Francesco Abate,Francesco Abate,Francesco Abate,Elena Lasorsa,Fabrizio Tabbò,Fabrizio Tabbò,Marcello Gaudiano,Marcello Gaudiano,Nicoletta Chiesa,Filomena Di Giacomo,Elisa Spaccarotella,Luigi Barbarossa,Elisabetta Ercole,Maria Todaro,Maria Todaro,Michela Boi,Michela Boi,Andrea Acquaviva,Elisa Ficarra,Domenico Novero,Andrea Rinaldi,Thomas Tousseyn,Andreas Rosenwald,Lukas Kenner,Lorenzo Cerroni,Alexander Tzankov,Maurilio Ponzoni,Marco Paulli,Dennis D. Weisenburger,Wing C. Chan,Javeed Iqbal,Miguel A. Piris,Alberto Zamò,Carmela Ciardullo,Davide Rossi,Gianluca Gaidano,Stefano Pileri,Stefano Pileri,Enrico Tiacci,Brunangelo Falini,Leonard D. Shultz,Laurence Mevellec,Jorge Vialard,Roberto Piva,Roberto Piva,Francesco Bertoni,Raul Rabadan,Giorgio Inghirami,Giorgio Inghirami,Giorgio Inghirami +51 more
TL;DR: By integrating massive sequencing strategies, this work provides a comprehensive characterization of driver genetic alterations (somatic point mutations, copy number alterations, and gene fusions) in ALK(-) ALCLs and identifies activating mutations of JAK1 and/or STAT3 genes that led to constitutive activation of the JAK/STAT3 pathway.
Journal ArticleDOI
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R. Parrilla Castellar,Elaine S. Jaffe,Jonathan W. Said,Steven H. Swerdlow,Rhett P. Ketterling,Ryan A. Knudson,Jagmohan S. Sidhu,Eric D. Hsi,Shridevi Karikehalli,Liuyan Jiang,George Vasmatzis,Sarah E. Gibson,Sarah L. Ondrejka,Alina Nicolae,Karen L. Grogg,Cristine Allmer,Kay M. Ristow,Wyndham H. Wilson,William R. Macon,Mark E. Law,James R. Cerhan,Thomas M. Habermann,Stephen M. Ansell,Ahmet Dogan,Matthew J. Maurer,Andrew L. Feldman +25 more
TL;DR: ALK-negative ALCL is a genetically heterogeneous disease with widely disparate outcomes following standard therapy, and DUSP22 and TP63 rearrangements may serve as predictive biomarkers to help guide patient management.
Journal ArticleDOI
Molecular pathogenesis of mantle cell lymphoma
TL;DR: The molecular pathways that contribute to pathogenesis are discussed, and how improved understanding of these molecular mechanisms offers new perspectives for the treatment of patients are offered.
Journal ArticleDOI
Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients
Roberto N. Miranda,Tariq N. Aladily,H. Miles Prince,Rashmi Kanagal-Shamanna,Daphne de Jong,Luis Fayad,Mitual Amin,Nisreen Haideri,Govind Bhagat,Glen S. Brooks,David A. Shifrin,Dennis P. O'Malley,Chan Yoon Cheah,Carlos E. Bacchi,Gabriela Gualco,Shiyong Li,John A. Keech,Ephram P. Hochberg,Matthew J. Carty,Summer E. Hanson,Eid Mustafa,Steven Sanchez,John T. Manning,Zijun Y. Xu-Monette,Alonso R. Miranda,Patricia S. Fox,Roland L. Bassett,Jorge J. Castillo,Brady E Beltran,Jan de Boer,Zaher Chakhachiro,Dongjiu Ye,Douglas P. Clark,Ken H. Young,L. Jeffrey Medeiros +34 more
TL;DR: Most patients with breast implant-associated ALCL who had disease confined within the fibrous capsule achieved complete remission, justifying cytotoxic chemotherapy in addition to removal of implants.
Journal ArticleDOI
Diffuse large B-cell lymphoma—treatment approaches in the molecular era
TL;DR: The next major breakthrough in DLBCL therapy during this 'molecular era' of disease definition will be the identification of combinations of novel agents that target the oncogenic drivers of these subsets.
Related Papers (5)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
Christine P. Hans,Dennis D. Weisenburger,Timothy C. Greiner,Randy D. Gascoyne,Jan Delabie,German Ott,H. Konrad Muller-Hermelink,Elias Campo,Rita M. Braziel,Elaine S. Jaffe,Zenggang Pan,Pedro Farinha,Lynette M. Smith,Brunangelo Falini,Alison H. Banham,Andreas Rosenwald,Louis M. Staudt,Joseph M. Connors,James O. Armitage,Wing C. Chan +19 more
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Ash A. Alizadeh,Michael B. Eisen,R. Eric Davis,Izidore S. Lossos,Andreas Rosenwald,Jennifer C. Boldrick,Hajeer Sabet,Truc Tran,Xin Yu,John Powell,Liming Yang,Gerald E. Marti,Troy Moore,James I. Hudson,Li-Sheng Lu,David B. Lewis,Robert Tibshirani,Gavin Sherlock,Wing C. Chan,Timothy C. Greiner,Dennis D. Weisenburger,James O. Armitage,Roger A. Warnke,Ronald Levy,Wyndham H. Wilson,M. R. Grever,John C. Byrd,David Botstein,Patrick O. Brown,Louis M. Staudt +29 more